Personalized cancer care support
The Colorectal Cancer Alliance provides personalized support and expert guidance for patients and families at every stage of the colorectal cancer experience —from diagnosis and treatment to clinical trials, survivorship, and end-of-life care
Let's get started
After completing the questions below, you will be contacted within 2 business days from our clinical navigation team.
Up Next
More about clinical trialsTop resources
FDA approves immunotherapy for MSI-H/dMMR stage II & III rectal cancer
The U.S. Food and Drug Administration approved dostarlimab (brand name Jemperli) as the first and only immunotherapy for adults with stage II or III rectal cancer that has a biomarker called MSI-H or dMMR.
A blood test that sees what scans can't
For many cancer patients, the end of active treatment brings a new kind of dread. Scans every few months and anxious waits for results. A blood test is changing that experience for a growing number of patients.
HAI therapy proves pivotal for pioneering patient
When Helen was diagnosed with metastatic colorectal cancer, the biggest concern for her medical team was that her cancer had spread to her liver. One type of therapy, hepatic artery infusion, offered a path forward, but there was a catch. Nobody at her hospital had ever done it before. She'd have to be first.